Atherosclerosis
Volume 197, Issue 2 , Pages 496-503 , April 2008

Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau

  • Gian Paolo Fadini

      Affiliations

    • Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova, Medical School, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Medicina Clinica e Sperimentale, Malattie del Metabolismo, Policlinico Universitario, Via Giustiniani, 2, 35100 Padova, Italy. Tel.: +39 049 8212185; fax: +39 049 8212184.
    • ,
  • Ilenia Baesso

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology, University of Padova, Medical School, Italy
    • ,
  • Mattia Albiero

      Affiliations

    • Department of Biomedical Sciences, University of Padova, Medical School, Italy
    • ,
  • Saverio Sartore

      Affiliations

    • Department of Biomedical Sciences, University of Padova, Medical School, Italy
    • ,
  • Carlo Agostini

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology, University of Padova, Medical School, Italy
    • ,
  • Angelo Avogaro

      Affiliations

    • Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova, Medical School, Italy

Received 26 September 2007 ,Revised 12 December 2007 ,Accepted 24 December 2007.

References 

  1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  2. Ergun S, Gehling UM. Nonbone marrow-derived endothelial progenitor cells: what is their exact location?. Circ Res. 2007;101:e31
  3. Aicher A, Rentsch M, Sasaki K, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007;100:581–589
  4. Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002;22:1567–1572
  5. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–438
  6. Fadini GP, Coracina A, Baesso I, et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke. 2006;37:2277–2282
  7. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–1457
  8. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26:2140–2146
  9. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1–E7
  10. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007;194:46–54
  11. Fadini GP, de Kreutzenberg SV, Coracina A, et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J. 2006;27:2247–2255
  12. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593–600
  13. Rosenzweig A. Circulating endothelial progenitors—cells as biomarkers. N Engl J Med. 2005;353:1055–1057
  14. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007
  15. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981–2987
  16. Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009–3017
  17. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–435
  18. Aicher A, Rentsch M, Sasaki KI, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007;100:581–589
  19. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol. 2007;292:1–18
  20. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom. 2005;64:1–8
  21. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417–2426
  22. Cheng J, Baumhueter S, Cacalano G, et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood. 1996;87:479–490
  23. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–5012
  24. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–3112
  25. Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science. 1999;285:1553–1558
  26. Tammela T, He Y, Lyytikka J, et al. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res. 2007;100:1468–1475
  27. Pelosi E, Valtieri M, Coppola S, et al. Identification of the hemangioblast in postnatal life. Blood. 2002;100:3203–3208
  28. Blann AD, Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?. Atherosclerosis. 2006;188:12–18
  29. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood. 2005;106:2923–2924
  30. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N. A CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 2006;98:e20–e25
  31. Case J, Mead LE, Bessler WK, et al. Human CD34(+)AC133(+)VEGFR-2(+) cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–1118
  32. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ Cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007;27:1572–1579
  33. Kondo T, Hayashi M, Takeshita K, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol. 2004;24:1442–1447
  34. Madeddu P, Emanueli C, Pelosi E, et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 2004;18:1737–1739
  35. Case J, Haneline LS, Yoder MC, Ingram DA. Reply to Fadini et al: critical assessment of putative endothelial progenitor phenotypes. Exp Hematol. 2007;35:1481–1482
  36. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752–2760
  37. Valgimigli M, Rigolin GM, Fucili A, et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110:1209–1212
  38. Leone AM, Rutella S, Bonanno G, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J. 2005;26:1196–1204
  39. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288–293
  40. Rookmaaker MB, Vergeer M, van Zonneveld AJ, Rabelink TJ, Verhaar MC. Endothelial progenitor cells: mainly derived from the monocyte/macrophage-containing CD34− mononuclear cell population and only in part from the hematopoietic stem cell-containing CD34+ mononuclear cell population. Circulation. 2003;108:e150;author reply e150
  41. Sharpe EE, Teleron AA, Li B, et al. The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells. Am J Pathol. 2006;168:1710–1721
  42. Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007;21:1141–1149
  43. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood. 2005;106:1525–1531
  44. Rohde E, Bartmann C, Schallmoser K, et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells. 2007;25:1746–1752
  45. Rohde E, Malischnik C, Thaler D, et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells. 2006;24:357–367
  46. Hur J, Yang HM, Yoon CH, et al. Identification of a novel role of t cells in postnatal vasculogenesis. Characterization of endothelial progenitor cell colonies. Circulation. 2007;116:1671–1682
  47. Yoder MC, Mead LE, Prater D, et al. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801–1809
  48. Guven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol. 2006;48:1579–1587
  49. Leor J, Marber M, Endothelial , Progenitors . A new tower of babel?. J Am Coll Cardiol. 2006;48:1588–1590
  50. Fadini GP, Agostini C, Avogaro A. Endothelial progenitor cells in coronary artery disease. J Am Coll Cardiol. 2007;49:1585;author reply 1585–1586
  51. Fadini GP, Agostini C, Avogaro A. Characterization of endothelial progenitor cells. Biochem Biophys Res Commun. 2005;336:1–2
  52. Shantsila E, Watson T, Tse HF, Lip GY. Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?. Ann Med. 2007;39:474–479
  53. Ballard VL, Edelberg JM. Stem cells and the regeneration of the aging cardiovascular system. Circ Res. 2007;100:1116–1127
  54. Rosenzweig A. Cardiac cell therapy—mixed results from mixed cells. N Engl J Med. 2006;355:1127–1274

PII: S0021-9150(08)00012-9

doi: 10.1016/j.atherosclerosis.2007.12.039

Atherosclerosis
Volume 197, Issue 2 , Pages 496-503 , April 2008

Article Tools

* Image Usage & Resolution